News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…
Patients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their…
Patients with breast cancer that has started to spread to the lymph nodes in the…
Taking part in an exercise programme reduced pain and fatigue, and improved quality of life…
Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have…
Subcutaneous injection of the immunotherapy nivolumab is non-inferior to intravenous delivery and dramatically reduces treatment…
The dual immunotherapy combination of nivolumab and ipilimumab reduced the risk of disease progression or…
The role of ctDNA, or liquid biopsy, as a predictive tool to guide and monitor…
Results from a new phase III study found that combining PD-L1 and TIGIT inhibitors plus…
The addition of durvalumab and bevacizumab to TACE significantly improved progression-free survival in patients with…